Back to news

Fundsmith Emerging - Director/PDMR Shareholding

Back to news
RNS Number : 2995R
Fundsmith Emerging Equities Tst PLC
13 June 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Rachel de Gruchy

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-executive Director of the Issuer

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Fundsmith Emerging Equities Trust plc

b)

 

LEI

 

 

2138003EL6XV8JYU8V55

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 1p shares

 

 

GB00BLSNND18

 

b)

 

Nature of the transaction

 

 

Acquisition of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1,267 pence per share

 

1,000

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

1,000 Ordinary 1p shares

 

1,267 pence per share

e)

 

Date of the transaction

 

 

13 June 2018

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

Name of authorised official of issuer responsible for making notification:

Kerstin Rucht, for and on behalf of Frostrow Capital LLP

Company Secretary to FUNDSMITH EMERGING EQUITIES TRUST PLC


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHLLFVFRDIVLIT